Monkeypox clinical disease: Literature review and a tool proposal for the monitoring of cases and contacts

Archive ouverte

Javelle, Emilie | Ficko, Cécile | Savini, Hélène | Mura, Marie | Ferraris, Olivier | Tournier, Jean Nicolas | de Laval, Franck

Edité par CCSD ; Elsevier -

International audience. The human monkeypox disease has mainly been described in Western and Central Africa. Since May 2022, the monkeypox virus has been spreading worldwide in a new epidemiological pattern, where cases result from person-to-person transmission, and develop clinically milder or less typical illness than during previous outbreaks in endemic areas. The newly-emerging monkeypox disease needs to be described over the long term, to improve cases definitions, to implement prompt control measures against epidemics, and to provide supportive care. Hence, we first conducted a review of historical and recent outbreaks to define the full clinical spectrum of the monkeypox disease and its course known so far. Then, we built a self-administrated questionnaire collecting daily symptoms of the monkeypox infection to follow cases and their contacts, even remotely. This tool will assist in the management of cases, the surveillance of contacts, and the conduct of clinical studies.

Suggestions

Du même auteur

Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them

Archive ouverte | de Laval, Franck | CCSD

International audience. This study presents the methods and results of the investigation into a SARS-CoV-2 outbreak in a professional community. Due to the limited testing capacity available in France at the time, w...

Biodefence research: what to fund now?

Archive ouverte | Simon, Fabrice | CCSD

International audience

COVID-19 Repeated Convalescent Plasma Collection: Analysis of 149 Donations from 88 French Military Health Workers

Archive ouverte | Conan, Pierre-Louis | CCSD

International audience. Background: Passive therapy with convalescent plasma (CP) could be an effective and safe treatment option in COVID-19 patients. Neutralizing antibodies present in CP generated in response to ...

Chargement des enrichissements...